Articles from IntegriChain

IntegriChain, the leading provider of pharma revenue optimization technology and insights, today announced the successful conclusion of its Access Insights Conference, co-hosted by Blue Fin Group, an IntegriChain company. The premier event, designed for commercial, operational, and financial executives and teams at pharmaceutical manufacturers, delivers high-level strategic insights alongside practical, real-world solutions, concluded with record-breaking attendance, solidifying its position as the industry leader.

IntegriChain, a leading provider of pharmaceutical revenue optimization technology and data intelligence, today announced the launch of its AI-powered State Price Transparency Reporting (SPTR) system. As state-level price transparency mandates continue to expand and evolve, IntegriChain is meeting the moment with a comprehensive, market-leading solution built on deep regulatory expertise, combined with advanced automation and real-time analytics.

IntegriChain, a market leader in net revenue optimization technology and insights for the life sciences industry, today announced a strategic leadership evolution within its Product and Technology organization, underscoring the company’s commitment to innovation. Shai Fiss has been appointed as the new Chief AI and Technology Officer (CAIO & CTO), effective August 18, 2025. Concurrently, Brad Burget, the current Chief Technology Officer, will transition to the role of CTO Emeritus.

IntegriChain, the leading provider of revenue optimization technology and insights for the pharmaceutical industry, today announced the hiring of Clay Willis. Willis brings IntegriChain more than a decade of experience in pharmaceutical consulting and advisory, predominantly around 340B, contracting, pricing, and market access issues.